PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35205815-7	2022	Our results show that CUDC-907 significantly inhibits NB proliferation and colony growth, induces apoptosis, blocks cell cycle progression, inhibits MYCN, and enhances H3K9Ac levels by inhibiting the PI3K/AKT signaling pathway and HDAC function.	CUDC-907	22-30	MYCN proto-oncogene, bHLH transcription factor	Homo sapiens	149-153	
35205815-7	2022	Our results show that CUDC-907 significantly inhibits NB proliferation and colony growth, induces apoptosis, blocks cell cycle progression, inhibits MYCN, and enhances H3K9Ac levels by inhibiting the PI3K/AKT signaling pathway and HDAC function.	CUDC-907	22-30	AKT serine/threonine kinase 1	Homo sapiens	205-208	
35205815-9	2022	Overall, our findings highlight that the dual inhibition of PI3K and HDAC by CUDC-907 is an effective therapeutic strategy for NB and other MYC-dependent cancers.	CUDC-907	77-85	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	140-143